|
HS Code |
290033 |
| Iupac Name | 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid |
| Molecular Formula | C16H21N3O4 |
| Molar Mass | 319.36 g/mol |
| Cas Number | 1421373-65-2 |
| Appearance | White to off-white solid |
| Solubility In Water | Slightly soluble |
| Storage Conditions | Store at -20°C, dry and protected from light |
| Canonical Smiles | CC(C)C1NC(=O)N(C1C2=NC=C(C(=C2)C(=O)O)COC)C |
| Inchi | InChI=1S/C16H21N3O4/c1-10(2)16-12(9-23-3)14(20)18(8-13(16)19)15(21)11-6-5-7-17-22-11/h5-7,10,12,16H,8-9H2,1-3H3,(H,19,20,21) |
| Logp | Estimated 1.8 |
As an accredited 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid in a sealed amber glass bottle with tamper-evident cap. |
| Container Loading (20′ FCL) | Container loading (20′ FCL): 20-foot container typically accommodates about 14–16 metric tons of this chemical, packed in sealed, approved drums. |
| Shipping | This chemical, **2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid**, is securely packaged in accordance with regulatory guidelines. It is shipped in sealed containers, accompanied by safety documentation, with temperature control and hazard labeling as required to ensure safe delivery and chemical integrity. |
| Storage | Store **2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid** in a tightly sealed container, away from light, moisture, and incompatible substances. Keep at 2–8°C (refrigerated conditions) in a well-ventilated area. Avoid exposure to heat and strong oxidizing agents. Use appropriate personal protective equipment when handling. |
| Shelf Life | Shelf life is typically 2-3 years when stored in a cool, dry place, tightly sealed, and protected from light. |
|
Purity 99%: 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid with purity 99% is used in pharmaceutical synthesis, where high purity ensures reproducible bioactivity outcomes. Melting point 184°C: 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid with a melting point of 184°C is used in solid-state formulation processes, where thermal stability supports precise processing control. Particle size <10 μm: 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid with particle size below 10 μm is used in advanced drug delivery systems, where fine particle distribution enhances dissolution rate. Molecular weight 292.34 g/mol: 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid with a molecular weight of 292.34 g/mol is used in lead compound optimization, where specific molecular mass facilitates targeted ligand interactions. Stability temperature up to 120°C: 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid stable up to 120°C is used in heated reaction vessels, where chemical integrity is maintained under process temperatures. |
Competitive 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
People ask what goes into the drive behind our production of 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid. It doesn't start and end at synthesis or quality tests. Every step begins with sharp attention to real needs in the field and the lab. We took notice of the growing interest in advanced pyridinecarboxylic acid derivatives, especially in pharmaceutical research and in the search for novel intermediates for active ingredients. Years ago, we met clients who struggled to source materials that reliably delivered both high purity and tightly controlled impurity profiles. Inconsistent batches led to ruined experiments and missed development targets. We chose not to watch from the sidelines. Our facility invested in detailed route development for this molecule, driving purity as high as feasible and focusing on supply reliability.
Making 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid takes far more than a reactor, solvent, and raw materials. Teams in production have seen the impact of temperature gradients on reaction profiles and the headache of micro-impurities that can tail into final isolation. We've spent seasons refining filtration steps and solvent recovery, not because it's easy, but because that gritty attention to detail’s been shown to make a major difference. The final product shows uniform batch-to-batch color and solubility, key for those trying to scale up downstream processes. Several partners in medicinal chemistry commented directly about how this eased their route planning and cut down time on analytical troubleshooting.
We manufacture this molecule to meet specifications that address both the chemical's own performance and the domino effects it brings into each customer's process. Specifying a minimum purity of 99 percent stems from direct conversations with researchers who saw minor impurities throw off chromatograms and create unpredictable results. Water content, if left unchecked, can lead to hydrolysis in sensitive applications, so we control it tightly through both Karl Fischer analysis and routine drying with modern instrumentation. Particle sizing impacts dissolution speed, so we monitor and adjust our milling technique based on customer feedback. No batch leaves our factory doors without passing through HPLC, MS, and NMR checks. Those may sound technical, but our staff knows firsthand that skipping these means higher odds of a failed reaction later for our partners. To us, these aren’t marketing points. They’re habits forged on the production line and in troubleshooting sessions with customers.
This pyridinecarboxylic acid derivative drew early attention from drug discovery teams and patent applications focused on heterocyclic building blocks with complex substitution. In the laboratory, the unique structure of the imidazolyl-pyridinecarboxylic framework encourages enzyme interaction and bioactivity routes that simpler analogs never quite match. Our chemists work directly with teams optimizing synthetic paths for kinase inhibitors, antifungal candidates, and agricultural active ingredients. The stability and reactivity profile mean this molecule can slot into several condensation and coupling schemes, opening up experimental routes for mid-stage intermediates.
Outside pharma research, some clients in agrochemical development use this compound for pilot studies where resistance management and compound diversity play central roles. Formulators appreciate the crystalline material because it offers a workable shelf life and consistent handling properties. For academic researchers, access to a reliable supply means that multi-step synthetic sequences can continue uninterrupted, without having to pause for custom sample resynthesis.
Customers often compare our 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid to both commercial standards and custom materials from international sources. Several factors stand out. First, we’ve witnessed the pain of delayed shipments and supply interruptions. Our approach—covering both small and mid-sized batch runs—addresses both common research lot sizes and emerging pilot project demands. We learned from early setbacks that flexibility in packaging matters. Our warehouse stocks both bulk jars and laboratory vials, cutting down unnecessary transfer steps in the customer’s workflow.
In terms of quality, direct side-by-side tests with globally sourced analogs showed reduced unknown peaks on HPLC and greater consistency in both color and melting profile for our product. Some material on the market carries nontrivial levels of solvent residue, adversely affecting sensitive synthetic applications. Through stepwise solvent screening and a thorough final drying regime, we keep residual solvent below detectable thresholds, which gives chemists more confidence regardless of their process. Over the years, we gathered detailed feedback from dozens of users who ranked our standard above off-the-shelf materials for both handling and process repeatability.
Another difference stems from our relationship with real users. Requests for documentation don’t end up in faceless queues. We maintain a modest but direct technical service team able to pull synthesis data, analytical reports, or impurity studies from our archives for customer projects. In some cases, feedback from a failed reaction or an analytical anomaly drove us to run supplemental impurity scouting and even prompted route optimization.
Quality comes from skilled individuals at each stage, not just from equipment or protocols. Our team trains on both hands-on operations and nearline analytical troubleshooting. Senior staff supervise sample draws and retain segregated reference lots for each production campaign. These practices didn't come from audit checklists—they were built from repeated troubleshooting of real-world issues, ranging from post-delivery instability to minor color shifts that signaled trace impurity or pH drift.
Team members take pride in knowing that their careful control over reaction scale-up and downstream processing gives working scientists a leg up. We sign off on every batch with personal accountability, knowing several clients rely on our consistency for GMP-analog studies or for application in regulatory filings. Rarely do we encounter the false comfort of “acceptable averages”. Each run faces checks that reach well beyond minimum tolerance.
It’s not lost on our team that chemical manufacturing brings environmental responsibility. Our engineers built solvent recycling into routine work, and our waste protocols use the latest data on local impact. We lower process mass intensity by continuous improvement—spacing out washes, switching to greener cleaning agents, and optimizing crystallization yields. No process is perfect, but every tweak adds up after thousands of liters. The local community benefits from consistent waste tracking, reduced solvent exposure for staff, and a safer, cleaner work environment.
Looking back, we saw several hurdles in meeting industry requirements. Introducing more stringent control over starting material traceability meant closer work with upstream suppliers. We sat down with them, walked through their analytics, and brought some in for joint troubleshooting when impurity tracking flagged unexpected patterns. This hands-on approach increased our confidence that what we deliver downstream carries the right assurance and predictability.
Scaling production always introduces new issues. Smaller volumes allow more precise hand-control, but as demand picked up, we had to rethink agitation, heating, and crystallization on a larger scale. We invested in automated controls, but never at the expense of real technician oversight. Every engineer in our plant can trace a process deviation to root cause because they’ve participated in hundreds of lab-scale and pilot-scale runs. That human connection keeps our operation honest and responsive to new demands.
Direct communication with research chemists and industry development managers remains key. We value the insight gained from learning how our product performs not just in our own QC lab, but in customer processes. Reports of solubility quirks led us to adjust milling settings. Observations about color changes pushed us to review stability samples at intervals up to twenty-four months. The mutual flow of experience shapes both the chemical and the support we provide.
We share process improvement notes with end-users committed to robust supply chains. Some partners work with us to design redundancy into orders, which lets us respond during market shortages and price spikes for precursors. Together, we built a level of reliability that extends from our plant through to the most demanding pilot lots and validation campaigns.
Our experience tells us researchers need more than just high-purity intermediates. Some projects benefit from application notes, impurity reference sets, or technical support for particular reaction conditions. We built our archive from actual project histories, sharing tips drawn from both successful batches and hard-earned setbacks. This collaborative, non-generic approach helps customers cut project times and limit avoidable pitfalls.
Clients working in patent-heavy fields often request confirmed batch traceability and archive samples. We back this up by holding reference lots under controlled conditions, available for additional analysis or cross-referencing months or even years after initial delivery.
Our production setup adapts as real-world requirements shift. Volatility in precursor markets can push schedules and influence material cost. By maintaining a diverse network of qualified suppliers, paired with regular internal audits, we limit exposure to shortages and sudden quality drops. Each quarter, we assess new analytical technologies, checking whether any improvements in impurity tracking or detection thresholds justify investment. In every case, these choices reflect the honest needs we see in both our own operation and in end-use laboratories and production sites.
No chemical exists in a vacuum. Regulatory changes, shifts in project focus among key clients, and advances in synthetic routes all motivate ongoing adjustment. We form working groups that include production staff, technical support, and commercial contacts, making sure everyone’s voice gets heard as the next phase of production planning unfolds.
Manufacturing 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1h-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid at scale calls for more than stock answers or generic claims. It draws on a real, lived understanding of both field demands and laboratory details. Over the years, we discovered that taking shortcuts has costs that ripple through research networks and development schedules. By taking the longer, steadier route—investing in quality, communication, and constant improvement—we give customers a source of material they can use with confidence, and we push ourselves to keep delivering in ways that matter, batch after batch.
By working at the intersection of high standards, practical experience, and responsible manufacturing practices, we stand behind each lot and value every conversation that helps us drive the process forward. We see each delivery not just as the end of a production run, but as the beginning of what researchers, developers, and innovators will create next. The story of this molecule, and the results it enables, continues to unfold with every project and every satisfied partner.